FoodJul 23, 2025
DANONE US YoCrunch Low Fat Yogurt with Toppers, Strawberry with milk recall — FDA H-0300-2025
Foreign material (plastic pieces)
Class IIFDA: TerminatedDANONE US LLC
July 2025 recalls — page 5
These records include useful source details for the selected month.
DrugJul 23, 2025
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle recall — FDA D-0521-2025
Subpotent Drug: Assay below the approved specification
Class IIFDA: OngoingACCORD HEALTHCARE, INC.
DrugJul 23, 2025
Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets recall — FDA D-0533-2025
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
Class IIFDA: OngoingAscend Laboratories, LLC
DrugJul 23, 2025
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottle recall — FDA D-0519-2025
Subpotent Drug: Assay below the approved specification
Class IIFDA: OngoingACCORD HEALTHCARE, INC.
DrugJul 23, 2025
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottle recall — FDA D-0522-2025
Subpotent Drug: Assay below the approved specification
Class IIFDA: OngoingACCORD HEALTHCARE, INC.
DrugJul 23, 2025
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle recall — FDA D-0524-2025
Subpotent Drug: Assay below the approved specification
Class IIFDA: OngoingACCORD HEALTHCARE, INC.
DrugJul 23, 2025
Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 90-count bottle recall — FDA D-0520-2025
Subpotent Drug: Assay below the approved specification
Class IIFDA: OngoingACCORD HEALTHCARE, INC.
DrugJul 23, 2025
Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles recall — FDA D-0516-2025
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25C, 60%RH).
Class IIFDA: OngoingSUN PHARMACEUTICAL INDUSTRIES INC
DrugJul 23, 2025
Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle recall — FDA D-0525-2025
Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
Class IIFDA: OngoingDr. Reddy's Laboratories, Inc.
DrugJul 23, 2025
Qualgen Testosterone 200 mg Pellet recall — FDA D-0517-2025
Labeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.
Class IIIFDA: OngoingQualgen, LLC
DrugJul 23, 2025
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle recall — FDA D-0518-2025
Subpotent Drug: Assay below the approved specification
Class IIFDA: OngoingACCORD HEALTHCARE, INC.
DrugJul 23, 2025
Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets recall — FDA D-0534-2025
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
Class IIFDA: OngoingAscend Laboratories, LLC
DrugJul 23, 2025
Central Admixture Pharmacy Services, Inc (CAPS) PERIPHERAL PARENTERAL NUTRITION, Compounded recall — FDA D-0530-2025
Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.
Class IIFDA: OngoingCentral Admixture Pharmacy Services, Inc (CAPS) Los…
DrugJul 23, 2025
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle recall — FDA D-0523-2025
Subpotent Drug: Assay below the approved specification
Class IIFDA: OngoingACCORD HEALTHCARE, INC.
DrugJul 23, 2025
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles recall — FDA D-0532-2025
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet…
Class IIFDA: OngoingLupin Pharmaceuticals Inc.
VehicleJul 17, 2025
Chrysler head restraint recall — NHTSA campaign 25V472000
Chrysler (FCA US, LLC) is recalling certain 2023-2024 Jeep Grand Cherokee and Jeep Grand Cherokee L vehicles. The second-row seat head restraints may not lock in the upright position. As…
head restraintChrysler (FCA US, LLC)
Medical DeviceJul 16, 2025
Optisite Arterial Cannula recall — FDA Z-2081-2025
due to complaints received for 3mm to 4mm section wire exposed/protruding from the outside of the cannula body.
Class IFDA: OngoingEdwards Lifesciences, LLC
Medical DeviceJul 16, 2025
GE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGING Varicam, Millennium VG, Millennium VG Hawkeye recall — FDA Z-2098-2025
Unintended radial detector motion may occur during patient setup or during patient scan if system does not have correct version of gantry software installed. Unintended detector motion may…
Class IIFDA: OngoingGE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGING
Medical DeviceJul 16, 2025
STRATASYS TrueDent White, TDM110, Model No recall — FDA Z-2094-2025
Customers unable to use cartridges due to formatting error in expiration date which leads to switching the day with the month. Or, the system will not recognize that a resin is expired and…
Class IIIFDA: CompletedSTRATASYS LTD
Medical DeviceJul 16, 2025
STRATASYS TrueDent Magenta, TDM130, Model No recall — FDA Z-2092-2025
Customers unable to use cartridges due to formatting error in expiration date which leads to switching the day with the month. Or, the system will not recognize that a resin is expired and…
Class IIIFDA: CompletedSTRATASYS LTD
Medical DeviceJul 16, 2025
Alcon Laboratories, Inc. Custom Pak recall — FDA Z-2110-2025
Due to the potential that some units within specific lots were damaged during the manufacturing process. The area of damage is within the same area of the lidding. While the damage in the…
Class IIFDA: OngoingAlcon Research LLC
Medical DeviceJul 16, 2025
Hummingbird Stimulated EMG Kit with Hummingbird recall — FDA Z-2100-2025
Product packaging contains the wrong part number and kit contents.
Class IIFDA: OngoingNeurovision Medical Products Inc.
Medical DeviceJul 16, 2025
FEM-FLEXII Femoral Arterial Cannula recall — FDA Z-2085-2025
due to complaints received for 3mm to 4mm section wire exposed/protruding from the outside of the cannula body.
Class IFDA: OngoingEdwards Lifesciences, LLC
Medical DeviceJul 16, 2025
FEM-FLEX II Femoral Arterial Cannula recall — FDA Z-2082-2025
due to complaints received for 3mm to 4mm section wire exposed/protruding from the outside of the cannula body.
Class IFDA: OngoingEdwards Lifesciences, LLC
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.